Skip to content

Study · In vitro (cells) · mouse · 2005

7 results

Gonadotropin-releasing hormone I analog acts as an antiapoptotic factor in mouse blastocysts.

Kawamura K, Fukuda J, Kumagai J, Shimizu Y, Kodama H, Nakamura A, Tanaka T

Endocrinology2 Jun 2005Cited by 31 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In mouse embryos, ganirelix acetate inhibited development beyond the expanded blastocyst stage.

    In plain wordsIn lab tests, ganirelix acetate inhibited mouse embryo development beyond the expanded blastocyst stage.

    Peptide
    Ganirelix
    Outcome
    DecreaseDevelopment beyond expanded blastocyst stage
    Study

    mousen: not reported in source

    preimplantation embryos and blastocysts
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In contrast, treatment with GnRH-I antagonist, ganirelix acetate, inhibited development of preimplantation embryos beyond the expanded blastocyst stage
    1 context sentence
    Summary · context
    In this study, we investigated the molecular mechanisms of GnRH-I in the regulation of early embryonic development in mouse.
  2. 02LabIn vitro (cells)Mechanism

    In mouse embryos, ganirelix acetate induced apoptosis.

    In plain wordsIn lab tests, ganirelix acetate induced programmed cell death in mouse embryos.

    Peptide
    Ganirelix
    Outcome
    IncreaseApoptosis
    Study

    mousen: not reported in source

    preimplantation embryos and blastocysts
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In contrast, treatment with GnRH-I antagonist, ganirelix acetate, inhibited development of preimplantation embryos beyond the expanded blastocyst stage and induced apoptosis
    1 context sentence
    Summary · context
    In this study, we investigated the molecular mechanisms of GnRH-I in the regulation of early embryonic development in mouse.
  3. 03LabIn vitro (cells)Mechanism

    In mouse blastocysts, ganirelix-induced cell death involved disruption of mitochondrial function.

    In plain wordsIn lab tests, ganirelix-induced death of mouse blastocyst cells involved disrupted mitochondrial function.

    Peptide
    Ganirelix
    Outcome
    Not applicableMitochondrial function disruption
    Study

    mousen: not reported in source

    preimplantation embryos and blastocysts
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    GnRH-I antagonist-induced cell death was mediated by disruption of mitochondrial function, release of cytochrome c, and activation of caspase-3.
    1 context sentence
    Summary · context
    In this study, we investigated the molecular mechanisms of GnRH-I in the regulation of early embryonic development in mouse.
  4. 04LabIn vitro (cells)Mechanism

    In mouse blastocysts, ganirelix-induced cell death involved cytochrome c release.

    In plain wordsIn lab tests, ganirelix-induced death of mouse blastocyst cells involved cytochrome c release.

    Peptide
    Ganirelix
    Outcome
    Not applicableCytochrome c release
    Study

    mousen: not reported in source

    preimplantation embryos and blastocysts
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    GnRH-I antagonist-induced cell death was mediated by disruption of mitochondrial function, release of cytochrome c, and activation of caspase-3.
    1 context sentence
    Summary · context
    In this study, we investigated the molecular mechanisms of GnRH-I in the regulation of early embryonic development in mouse.
  5. 05LabIn vitro (cells)Mechanism

    In mouse blastocysts, ganirelix-induced cell death involved caspase-3 activation.

    In plain wordsIn lab tests, ganirelix-induced death of mouse blastocyst cells involved caspase-3 activation.

    Peptide
    Ganirelix
    Outcome
    Not applicableCaspase-3 activation
    Study

    mousen: not reported in source

    preimplantation embryos and blastocysts
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    GnRH-I antagonist-induced cell death was mediated by disruption of mitochondrial function, release of cytochrome c, and activation of caspase-3.
    1 context sentence
    Summary · context
    In this study, we investigated the molecular mechanisms of GnRH-I in the regulation of early embryonic development in mouse.
  6. 06LabIn vitro (cells)Mechanism

    In mouse blastocysts, ganirelix decreased epidermal growth factor expression.

    In plain wordsIn lab tests, ganirelix decreased epidermal growth factor expression in mouse blastocysts.

    Peptide
    Ganirelix
    Outcome
    DecreaseEpidermal growth factor expression
    Study

    mousen: not reported in source

    preimplantation embryos and blastocysts
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Furthermore, treatment with GnRH-I antagonist decreased expression of two antiapoptotic growth factors, epidermal growth factor and IGF-II, in blastocysts.
    1 context sentence
    Summary · context
    In this study, we investigated the molecular mechanisms of GnRH-I in the regulation of early embryonic development in mouse.
  7. 07LabIn vitro (cells)Mechanism

    In mouse blastocysts, ganirelix decreased IGF-II expression.

    In plain wordsIn lab tests, ganirelix decreased IGF-II expression in mouse blastocysts.

    Peptide
    Ganirelix
    Outcome
    DecreaseIGF-II expression
    Study

    mousen: not reported in source

    preimplantation embryos and blastocysts
    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Furthermore, treatment with GnRH-I antagonist decreased expression of two antiapoptotic growth factors, epidermal growth factor and IGF-II, in blastocysts.
    1 context sentence
    Summary · context
    In this study, we investigated the molecular mechanisms of GnRH-I in the regulation of early embryonic development in mouse.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.